Literature DB >> 16235186

The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection.

Robert C Brunham1, Babak Pourbohloul, Sunny Mak, Rick White, Michael L Rekart.   

Abstract

BACKGROUND: After the introduction of a program to control Chlamydia trachomatis infection in British Columbia, Canada, case rates fell from 216 cases/100,000 population in 1991 to 104 cases/100,000 population in 1997. Since 1998, rates have increased, and case counts now exceed those recorded before the intervention.
METHODS: We used Cox proportional-hazards survival analysis and developed a compartmental mathematical model to investigate the cause of resurgence in chlamydia cases.
RESULTS: Cox proportional-hazards survival analysis showed that the relative risk of C. trachomatis reinfection has increased 4.6% per year since 1989, with the increased risk greatest among the young and greater among women than men. A compartmental mathematical model of C. trachomatis transmission showed that a control strategy based on shortening the average duration of infection results in an early reduction in prevalence followed by a rebound in prevalence, reproducing the observed trends.
CONCLUSIONS: We speculate that a C. trachomatis infection control program based on early case identification and treatment interferes with the effects of immunity on population susceptibility to infection and that, in the absence of strategies to alter sexual networks, a vaccine will be needed to halt the spread of infection at the population level.

Entities:  

Mesh:

Year:  2005        PMID: 16235186     DOI: 10.1086/497341

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  102 in total

1.  The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection.

Authors:  Melissa M Riley; Matthew A Zurenski; Lauren C Frazer; Catherine M O'Connell; Charles W Andrews; Margaret Mintus; Toni Darville
Journal:  Infect Immun       Date:  2012-03-19       Impact factor: 3.441

Review 2.  Human and Pathogen Factors Associated with Chlamydia trachomatis-Related Infertility in Women.

Authors:  S Menon; P Timms; J A Allan; K Alexander; L Rombauts; P Horner; M Keltz; J Hocking; W M Huston
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

3.  The role of reinfection and partner notification in the efficacy of Chlamydia screening programs.

Authors:  Janneke C M Heijne; Christian L Althaus; Sereina A Herzog; Mirjam Kretzschmar; Nicola Low
Journal:  J Infect Dis       Date:  2010-12-24       Impact factor: 5.226

4.  Chlamydia-specific CD4 T cell clones control Chlamydia muridarum replication in epithelial cells by nitric oxide-dependent and -independent mechanisms.

Authors:  Krupakar Jayarapu; Micah Kerr; Susan Ofner; Raymond M Johnson
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

5.  Enhancement of the protective efficacy of a Chlamydia trachomatis recombinant vaccine by combining systemic and mucosal routes for immunization.

Authors:  Pooja Ralli-Jain; Delia Tifrea; Chunmei Cheng; Sukumar Pal; Luis M de la Maza
Journal:  Vaccine       Date:  2010-09-25       Impact factor: 3.641

Review 6.  Screening programmes for chlamydial infection: when will we ever learn?

Authors:  Nicola Low
Journal:  BMJ       Date:  2007-04-07

7.  Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.

Authors:  Delia F Tifrea; Sukumar Pal; Jean-Luc Popot; Melanie J Cocco; Luis M de la Maza
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

8.  Cost-Effectiveness of Opt-Out Chlamydia Testing for High-Risk Young Women in the U.S.

Authors:  Kwame Owusu-Edusei; Karen W Hoover; Thomas L Gift
Journal:  Am J Prev Med       Date:  2016-03-04       Impact factor: 5.043

9.  Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles.

Authors:  Michelle L Zaharik; Tarun Nayar; Rick White; Caixia Ma; Bruce A Vallance; Nadine Straka; Xiaozhou Jiang; Jose Rey-Ladino; Caixia Shen; Robert C Brunham
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

10.  A randomized trial of home versus clinic-based sexually transmitted disease screening among men.

Authors:  Mary M Reagan; Hanna Xu; Shirley L Shih; Gina M Secura; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-11       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.